Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Finance
    3. >Russia overhauls vaccine production after cattle disease triggers mass culling
    Finance

    Russia Overhauls Vaccine Production After Cattle Disease Triggers Mass Culling

    Published by Global Banking & Finance Review®

    Posted on March 30, 2026

    2 min read

    Last updated: March 30, 2026

    Add as preferred source on Google
    Russia overhauls vaccine production after cattle disease triggers mass culling - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:FinanceagricultureRussiaBiotechnology

    Quick Summary

    President Putin has signed a decree forming the Russian Biological Industry Company, consolidating state vaccine producers to boost self-sufficiency amid a cattle disease outbreak in Siberia that sparked rare farmer protests.

    Russia Revamps Animal Vaccine Industry After Cattle Disease Sparks Crisis

    Government Response and Industry Overhaul

    MOSCOW, March 30 - Russian President Vladimir Putin signed a decree on Monday overhauling the production of animal vaccines following an outbreak of cattle disease that led to the deeply unpopular mass culling of livestock in a Siberian region.

    Public Reaction and Political Fallout

    The deaths of thousands of animals in Novosibirsk region sparked rare protests in wartime Russia and prompted calls by farmers for the resignation of top government officials overseeing agriculture. 

    Structural Changes in Vaccine Production

    Putin's decree merged several state-owned enterprises in different parts of the country into one entity - the Russian Biological Industry Company.

    Objectives of the Decree

    It said the measure was aimed at "securing technological independence, sustainable development, and encouraging investment in the field of veterinary medicine".

    Causes and Spread of the Outbreak

    Russian authorities have blamed pasteurellosis and rabies for the outbreak that has spread to other areas. The head of a local state veterinary service also said that irregular vaccination on local small farms had led to a mutation of the pathogen.

    International Reports and Allegations

    In a report published on March 20, the U.S. Department of Agriculture's Foreign Agricultural Service cited "local sources and trading contacts" who alleged that "the scale of these measures may indicate an unconfirmed outbreak of foot-and-mouth disease".

    Concerns Over Vaccine Adequacy

    It added that the authorities' response to the outbreak "raised concerns about the adequacy of current vaccines and the potential impact on Russia's cattle trade".

    Official Russian Response

    Russia's agriculture watchdog dismissed the allegations in the U.S. report and said that planned vaccinations against foot-and-mouth disease have been carried out in the Novosibirsk region since 2022 and are routinely monitored by the agency.

    Shifts in Vaccine Production and Imports

    Russia imported up to 70% of its animal vaccines before 2022, when it was hit by Western sanctions in response to its military action in Ukraine.

    Increase in Domestic Vaccine Production

    In 2024, agriculture watchdog chief Sergei Dankvert said the situation had reversed, with up to 70% of vaccines being produced domestically.

    Expansion of Leading Producer

    The agency said that Russia's leading producer, Shchelkovo Biokombinat, one of the companies now being merged, was expected to increase production tenfold in 2024 compared with 2021.

    (Reporting by Gleb Bryanski and Olga Popova; Editing by Andrew Heavens)

    Table of Contents

    Key Takeaways

    • •Putin’s new decree merges several state-owned animal vaccine enterprises into the Russian Biological Industry Company to enhance domestic capacity and attract investment.
    • •The outbreak in Novosibirsk—attributed to pasteurellosis, rabies, and a suspected mutation—led to thousands of livestock being culled, triggering protests and raising questions about vaccine efficacy.
    • •Prior to the 2022 sanctions, Russia imported up to 70% of its animal vaccines; since then, domestic production has surged, with 2024 vaccine output rising by 52% to 32 billion doses and exports growing over 20%.

    Frequently Asked Questions about Russia overhauls vaccine production after cattle disease triggers mass culling

    1Why did Russia overhaul its animal vaccine production?

    Russia restructured its animal vaccine production after an outbreak of cattle disease in Novosibirsk led to mass culling and farmer protests.

    2What changes did President Putin's decree make to the vaccine industry?
    • Government Response and Industry Overhaul
    • Public Reaction and Political Fallout
    • Structural Changes in Vaccine Production
    • Objectives of the Decree
    • Causes and Spread of the Outbreak
    • International Reports and Allegations
    • Concerns Over Vaccine Adequacy
    • Official Russian Response
    • Shifts in Vaccine Production and Imports
    • Increase in Domestic Vaccine Production
    • Expansion of Leading Producer

    The decree merged several state-owned enterprises into the Russian Biological Industry Company to improve technological independence and investment.

    3What diseases were blamed for the cattle outbreak in Russia?

    Russian authorities cited pasteurellosis and rabies as causes of the outbreak, with concerns about possible mutations due to irregular vaccination.

    4How has Russia's vaccine production changed since Western sanctions?

    Before 2022, Russia imported up to 70% of animal vaccines, but now up to 70% are produced domestically following investment in local capacity.

    5What impact could the outbreak have on Russia's cattle trade?

    The outbreak has raised concerns about vaccine adequacy and may affect the safety and volume of Russia’s cattle exports, according to USDA reports.

    More from Finance

    Explore more articles in the Finance category

    Image for Russia suspends FX transactions under budget rule until July 1
    Russia Suspends Fx Transactions Under Budget Rule Until July 1
    Image for European, African oil market gets tighter as Asia buys more
    European, African Oil Market Gets Tighter as Asia Buys More
    Image for UK regulator lowers car finance mis-selling bill to $12 billion
    UK Regulator Lowers Car Finance Mis-Selling Bill to $12 Billion
    Image for Italy data protection agency fines Intesa Sanpaolo $36 million over data breach
    Italy Data Protection Agency Fines Intesa Sanpaolo $36 Million Over Data Breach
    Image for Microsoft unveils AI upgrades, rolls out Copilot Cowork to early-access customers
    Microsoft Unveils AI Upgrades, Rolls Out Copilot Cowork to Early-Access Customers
    Image for Italy adopts rules that help credit fund expansion
    Italy Adopts Rules That Help Credit Fund Expansion
    Image for German special commission on health insurance proposes measures to cap costs
    German Special Commission on Health Insurance Proposes Measures to Cap Costs
    Image for Iran war is dimming outlook for many economies, IMF says
    Iran War Is Dimming Outlook for Many Economies, IMF Says
    Image for Siemens plans reorganisation of two divisions, says source
    Siemens Plans Reorganisation of Two Divisions, Says Source
    Image for Vertical Aerospace secures financing package of up to $850 million
    Vertical Aerospace Secures Financing Package of up to $850 Million
    Image for France arrests two more suspects on Bank of America's foiled attack
    France Arrests Two More Suspects on Bank of America's Foiled Attack
    Image for Volvo Cars to import Lynk & Co cars to Europe 
    Volvo Cars to Import Lynk & Co Cars to Europe 
    View All Finance Posts
    Previous Finance PostItaly Data Protection Agency Fines Intesa Sanpaolo $36 Million Over Data Breach
    Next Finance PostMicrosoft Unveils AI Upgrades, Rolls Out Copilot Cowork to Early-Access Customers